CROWELL & MORING LLP

Lobbying for NOVAVAX, INC. · Biotechnology

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate · $50,000.00 income · posted Apr 21, 2025

Lobbying activity 1

Health Issues

Vaccine policy Pandemic and All-Hazards Preparedness Act reauthorization

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem